Up more than 125% in a year, can this ASX 200 stock rise further?

This ASX 200 stock continues to storm higher.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • The ASX 200 Index is up 1.27% today, but Bravura shares have surged 125.26% year on year, driven by recent strong guidance updates.
  • Bravura expects FY26 revenue of $265 to $275 million and upgraded its EBITDA guidance, boosting investor confidence and leading to a 10.5% share increase today.
  • Macquarie raised its target price for Bravura to $3.02, reflecting valuation upgrades, despite noting potential revenue headwinds from customer exits announced in 2022.

The S&P/ASX 200 Index (ASX: XJO) is climbing higher today, up 1.27% at the time of writing. For the year, it is 9.27% higher.

It's decent growth for the past 12-month period, but there is one stock that has far outpaced the index and shot up significantly faster.

The Bravura Solutions Ltd (ASX: BVS) share price has risen an impressive 125.26% year on year. The majority of growth (54.6%) has happened in the past month. For today alone, the share price has jumped 10.54% higher and is changing hands at $3.295 a piece. 

Stock market chart in green with a rising arrow symbolising a rising share price.

Image source: Getty Images

Why is the ASX 200 share storming higher?

Investors have been buying the shares of the wealth management software solutions provider this week following its latest guidance update. 

Bravura said it expects FY26 revenue to be between $265 million and $275 million, which is ahead of last year's $256.8 million result. The business cites the continued strength of the British pound, higher project revenue, and continued focus on operational efficiency for the uplift.

The company also upgraded its EBITDA guidance to between $55 million and $65 million. This is higher than its FY25 result of $50 million.

And now Macquarie Group Ltd (ASX: MQG) has updated its guidance on the ASX 200 share.

Macquarie's outlook for Bravura shares

In a recent note to investors, the broker confirmed its neutral stance on Bravura shares. It also raised its target price to $3.02. Macquarie's latest guidance was for $2.03 in August.

At the time of writing, the new target price represents a potential downside of 8.3% over the next 12 months.

"Valuation: TP raised to $3.02 (from $2.03), reflecting upgrades. We have also removed the discount we applied to the terminal growth assumption, to reflect ongoing performance," Macquarie analysts said.

"Neutral. While we have upgraded earnings and our target price, the share price movement ahead of the update and in reaction to the release captures is in-line with our valuation."

What else did Macquarie have to say?

The broker said that the initial FY26 guidance noted that underlying revenue growth was expected to be driven by existing customers in EMEA and APAC and cross-sell opportunities in tandem with some new business wins. But added that no new customer wins were announced with the trading update.

Macquarie also said that the guidance upgrade comes despite a "drag from customer exits announced in 2022, that have remained clients". 

"One of three customer exits disclosed in Nov 2022 was expected to complete migration to a BPO by 1 Jan 2026. This customer generated A$10m revenue in FY25 and was not part of the reported FY25 attrition. This implies ~$5m FY26 revenue headwind. One of the other three customer exits from 2022 remains a client."

Also, exits or reductions in FY25 were expected to have a further 2.5% (or A$6.5m) revenue headwind in FY26.

Macquarie added: "While the upgrade calls out continued GBP strength, since guidance was issued at the result, the GBP has actually slightly weakened vs the AUD."

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Bravura Solutions and Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Technology Shares

Army man and woman on digital devices.
Technology Shares

What is Bell Potter saying about DroneShield and EOS shares this week?

The broker has given its verdict on these two popular shares.

Read more »

A woman looks quizzical as she looks at a graph of the share market.
Technology Shares

Hub24 vs Netwealth: Which ASX tech stock is the better buy now?

Both rivals are expanding, but one faster than the other.

Read more »

Smiling couple looking at a phone at a bargain opportunity.
Technology Shares

3 bargain ASX tech shares I'd buy right now

Tech shares have sold off, but that could be creating opportunities.

Read more »

defence personnel operating and discussing defence technology
Technology Shares

Why EOS shares are tumbling 11% today as investors weigh a key defence catalyst

EOS shares fall 11% as investors await a key contract update.

Read more »

Buy and sell written on a white cube.
Technology Shares

Why this top fundie is tipping Life360 shares for outsized gains

A leading fund manager believes Life360’s beaten-down shares could be set for a large rebound.

Read more »

Robot humanoid using artificial intelligence on a laptop.
Technology Shares

Xero shares push higher on deal with AI giant Anthropic

This tech stock is avoiding the market selloff on Friday.

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Technology Shares

Why are Weebit Nano shares crashing 15% today?

Let's see why this tech stock is sinking on Friday.

Read more »

A woman scratches her head, thinking is this a no-brainer?
Technology Shares

Down 65%: Are Pro Medicus shares in the buy zone yet?

Pro Medicus has had one of its toughest periods yet...

Read more »